NYSE:JWS Jaws Acquisition (JWS) Stock Price, News & Analysis → The World's First '$20 Trillion Drug?' (From Behind the Markets) (Ad) Free JWS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$11.76▼$14.8652-Week Range N/AVolume159,142 shsAverage Volume904,340 shsMarket Capitalization$198.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisSocial MediaStock AnalysisSocial Media Get Jaws Acquisition alerts: Email Address Ad Behind the MarketsThe World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>> About Jaws Acquisition Stock (NYSE:JWS)Jaws Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or entities. The company was incorporated in 2019 and is based in Miami Beach, Florida. Jaws Acquisition Corp. is a subsidiary of Jaws Sponsor LLC.Read More Ad Behind the MarketsThe World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>> JWS Stock News HeadlinesJuly 1, 2023 | morningstar.comJaws Juggernaut Acquisition Corp Class AJanuary 15, 2023 | dailymail.co.ukRihanna works her curves in VERY sexy lace catsuit as she drops jaws in sensual adApril 25, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.January 12, 2023 | ftw.usatoday.comWatch: Jaws-like panic grips beachgoers, who flee surf in terrorOctober 16, 2022 | dailymail.co.ukDining out! Elusive black shark that EJECTS its jaws out of its mouth looks like Marvel's Venom' because of its extendable jaw and needle-like teethSeptember 25, 2022 | investing.comJaws Hurricane Acquisition Corp (HCNE)August 20, 2022 | yahoo.comOlivia Newton-John Honored: 135 AMC Theaters Showing 'Grease' in Aid of Breast Cancer ResearchAugust 19, 2022 | msn.com'Honest assessment of the past': Community Hero Steve Murray, keeper of Alabama's true historyApril 25, 2024 | Wall Street Star (Ad)AI finds its first serious applicationAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.May 15, 2022 | prnewswire.comCANO FINAL DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Cano Health, Inc. f/k/a Jaws Acquisition Corp. Investors With Losses Exceeding $100K to Secure Counsel Before Important May 17 Deadline in Securities Class Action - CANO, CANO.WS, JWS, JWS.U, JWS WSMay 14, 2022 | benzinga.comCANO TUESDAY DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages Cano Health, Inc. f/k/a Jaws Acquisition Corp. Investors With Losses Over $100K to Secure Counsel Before Important May 17 Deadline in Securities Class Action – CANO, CANO.WS, JWS, JWS.U, JWS WSApril 23, 2022 | prnewswire.comROSEN, A LEADING LAW FIRM, Encourages Cano Health, Inc. f/k/a Jaws Acquisition Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CANO, CANO.WS, JWS, JWS.U, JWS WSApril 22, 2022 | benzinga.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cano Health, Inc. f/k/a Jaws Acquisition Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – CANO, CANO.WS, JWS, JWS.U, JWS WSApril 17, 2022 | benzinga.comROSEN, A TOP RANKED FIRM, Encourages Cano Health, Inc. f/k/a Jaws Acquisition Corp. Investors With Losses Over $100K to Secure Counsel Before Important May 17 Deadline in Securities Class Action – CANO, CANO.WS, JWS, JWS.U, JWS WSApril 1, 2022 | benzinga.comDEADLINE ALERT for GRAB, CANO, VRT, and VLTA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of ShareholdersMarch 30, 2022 | morningstar.comCano Health Inc Ordinary Shares - Class A CANOMarch 27, 2022 | benzinga.comCANO DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Cano Health, Inc. f/k/a Jaws Acquisition Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - CANO; CANO/WS; JWS; JWS.U; JWS WSMarch 22, 2022 | stockhouse.comCANO SHAREHOLDER ALERT: Robbins LLP Reminds Investors of Class Action Against Cano Health, Inc. (CANO, CANO/WS) f/k/a Jaws Acquisition Corp. (JWS)September 15, 2021 | msn.comZomato to shut grocery service and invest in Grofers - Here's whyAugust 8, 2021 | investing.comJaws Acquisition Corp (CANO)See More Headlines Receive JWS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jaws Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Offices & Clinics Of Medical Doctors Sub-IndustryN/A Current SymbolNYSE:JWS CUSIPN/A CIKN/A Webwww.jawsholdings.com Phone203 422 7700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-28,880,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-940.21% Return on Assets-6.80% Debt Debt-to-Equity RatioN/A Current Ratio0.20 Quick Ratio0.56 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$6.45 per share Price / BookN/AMiscellaneous Outstanding Shares86,250,000Free FloatN/AMarket Cap$198.38 million OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Joseph Leo Dowling (Age 56)Chief Exec. Officer Mr. Michael Racich (Age 49)Chief Financial Officer Key CompetitorsOncology InstituteNASDAQ:TOISHL TelemedicineNASDAQ:SHLTPono Capital TwoNASDAQ:PTWOLifeMDNASDAQ:LFMDAunaNYSE:AUNAView All Competitors This page (NYSE:JWS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaws Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
